We have also developed an epigenetic RPPA platform for histone marks and chromatin modifying proteins. For updated antibody lists by RPPA, check the Antibodies List. Pathways of the 260 antibodies: ...

CARLSBAD, Calif., Oct. 30, 2024 /PRNewswire/ -- ALZpath, Inc., a leading developer of innovative diagnostic tools and solutions for Alzheimer's disease and related dementias, today announced that ...

today announced that it has been honored in TIME's annual Best Inventions list, which features 200 extraordinary innovations changing our lives. The ALZpath proprietary pTau 217 antibody was ...